相似文献
1
KSNM60: The History of Radiopharmaceutical Sciences in Korea.
Nucl Med Mol Imaging. 2022 Jun;56(3):114-126. doi: 10.1007/s13139-022-00744-8. Epub 2022 Apr 5.
2
Chemistry and radiochemistry of As, Re and Rh isotopes relevant to radiopharmaceutical applications: high specific activity radionuclides for imaging and treatment.
Dalton Trans. 2017 Oct 31;46(42):14677-14690. doi: 10.1039/c7dt02407j.
3
Consensus nomenclature rules for radiopharmaceutical chemistry - Setting the record straight.
Nucl Med Biol. 2017 Dec;55:v-xi. doi: 10.1016/j.nucmedbio.2017.09.004. Epub 2017 Oct 2.
4
Radiotracers for positron emission tomography imaging.
MAGMA. 2013 Feb;26(1):149-58. doi: 10.1007/s10334-012-0356-1. Epub 2012 Dec 16.
5
Method to Development of PET Radiopharmaceutical for Cancer Imaging.
Methods Mol Biol. 2022;2413:13-22. doi: 10.1007/978-1-0716-1896-7_3.
6
Recent advances and impending challenges for the radiopharmaceutical sciences in oncology.
Lancet Oncol. 2024 Jun;25(6):e236-e249. doi: 10.1016/S1470-2045(24)00030-5.
7
Operational radiation safety for PET-CT, SPECT-CT, and cyclotron facilities.
Health Phys. 2008 Nov;95(5):554-70. doi: 10.1097/01.HP.0000327651.15794.f7.
8
Reactor produced [Cu]CuCl as a PET radiopharmaceutical for cancer imaging: from radiochemistry laboratory to nuclear medicine clinic.
Ann Nucl Med. 2020 Dec;34(12):899-910. doi: 10.1007/s12149-020-01522-2. Epub 2020 Oct 13.
9
Proceedings of international symposium of trends in radiopharmaceuticals 2023 (ISTR-2023).
EJNMMI Radiopharm Chem. 2023 Nov 10;8(1):39. doi: 10.1186/s41181-023-00224-0.
10
Targetry and radiochemical methods for the simultaneous cyclotron production of no-carrier-added radiopharmaceutical-quality 100Pd, 97Ru and 101mRh.
Int J Rad Appl Instrum A. 1987;38(2):151-7. doi: 10.1016/0883-2889(87)90013-x.
本文引用的文献
1
Ultrasensitive detection of malignant melanoma using PET molecular imaging probes.
Proc Natl Acad Sci U S A. 2020 Jun 9;117(23):12991-12999. doi: 10.1073/pnas.1922313117. Epub 2020 May 21.
2
Synthesis and characterization of Cu- and Cy5.5-labeled tetraiodothyroacetic acid derivatives for tumor angiogenesis imaging.
Bioorg Med Chem. 2020 Jan 1;28(1):115212. doi: 10.1016/j.bmc.2019.115212. Epub 2019 Nov 9.
3
-(2-(Dimethylamino)Ethyl)-4-F-Fluorobenzamide: A Novel Molecular Probe for High-Contrast PET Imaging of Malignant Melanoma.
J Nucl Med. 2019 Jul;60(7):924-929. doi: 10.2967/jnumed.118.221416. Epub 2018 Dec 14.
4
Naphthol Blue Black and Tc-Labeled Mannosylated Human Serum Albumin (Tc-MSA) Conjugate as a Multimodal Lymph Node Mapping Nanocarrier.
Sci Rep. 2018 Sep 11;8(1):13636. doi: 10.1038/s41598-018-31933-1.
5
Emerging Tracers for Nuclear Cardiac PET Imaging.
Nucl Med Mol Imaging. 2018 Aug;52(4):266-278. doi: 10.1007/s13139-018-0521-1. Epub 2018 May 8.
6
Cu-Labeled Repebody Molecules for Imaging of Epidermal Growth Factor Receptor-Expressing Tumors.
J Nucl Med. 2018 Feb;59(2):340-346. doi: 10.2967/jnumed.117.197020. Epub 2017 Sep 15.
7
Radiolabeled Phosphonium Salts as Mitochondrial Voltage Sensors for Positron Emission Tomography Myocardial Imaging Agents.
Nucl Med Mol Imaging. 2016 Sep;50(3):185-95. doi: 10.1007/s13139-016-0397-x. Epub 2016 Feb 29.
8
Preclinical anaylses of [F]cEFQ as a PET tracer for imaging metabotropic glutamate receptor type 1 (mGluR1).
J Cereb Blood Flow Metab. 2017 Jun;37(6):2283-2293. doi: 10.1177/0271678X16663948. Epub 2016 Jan 1.
9
Development of a complementary PET/MR dual-modal imaging probe for targeting prostate-specific membrane antigen (PSMA).
Nanomedicine. 2016 May;12(4):871-879. doi: 10.1016/j.nano.2015.12.368. Epub 2015 Dec 29.
10
Development of (68)Ga-labeled multivalent nitroimidazole derivatives for hypoxia imaging.
Bioorg Med Chem. 2015 Dec 15;23(24):7743-50. doi: 10.1016/j.bmc.2015.11.024. Epub 2015 Nov 22.
Zotero 插件